opinions are my own
Ann Arbor, MI
Joined June 2011
- Tweets1.2K
- Following281
- Followers441
- Likes3.4K
Pinned Tweet
✨ DREAMS DO COME TRUE ✨ Thank you @ratemyskyperoom
Victoria Nachar retweeted
💡 🧠 Hot off the press in its entirety... Our multi-center study looking into the safety of MMR vaccination in patients with myeloma receiving daratumumab maintenance after ASCT! Out now in @BloodPortfolio #BloodNeoplasia doi.org/10.1016/j.bneo.2026.…
Victoria Nachar retweeted
Getting excited to present our multi-center oral abstract at #ASH25 Saturday at 5:15pm investigating safety of MMR vaccines in patients on dara maintenance @kczmj @VictoriaNachar @KLratermann @AMDominickDO @KG_PharmD
Victoria Nachar retweeted
10/ #ASH25 Abstract 720: 1st-line CRS Tx with dex in #MMsm bsAbs (McElwee @thisisJamesD et al)
"Pocket dex": equal efficacy, way cheaper / simpler than toci, albeit >1 dose more likely.
This makes outpt bsAb SUD *way* easier for pts.
As I now say:
#Downwithdex
#ExceptforCRS !
Victoria Nachar retweeted
Check out our latest episode, "Chill for 5: The Febrile Neutropenia Survival Guide"! Plus find out why @ajperissinotti was laughing at @Berninini for wearing this ridiculous tuque ❄️#wolverheme #leusm open.spotify.com/episode/2py…
Victoria Nachar retweeted
We're BACK after a summer break! Listen to our latest episode "Prophy and Pints"! Let us de-mystify antimicrobial prophylaxis and help you choose the best regimen for your patients! 🦠💊 @Berninini @ajperissinotti open.spotify.com/episode/20O…
Victoria Nachar retweeted
Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma | Blood Cancer Journal nature.com/articles/s41408-0…
Me, in my car. Well done @WolverHeme
🔔We had to convene an emergency meeting with @dgermain21 and @ManniMD1 just for this episode ‼️ "ODAC - Our Decisions Are Confusing"
@ajperissinotti @Berninini
creators.spotify.com/pod/sho…
Victoria Nachar retweeted
Check out are latest episode, with a star-studded cast! 🤩 "Dex and the Cytokine City: Managing CRS with Bispecifics" #leusm #lymsm #myeloma #TwitteRx @berninini @thisisJamesD @VictoriaNachar @ajperissinotti @PharmacistOnc creators.spotify.com/pod/sho…
Victoria Nachar retweeted
📘 Dive into BCMA-directed therapies for MM and strengthen your treatment approach with new data!
📍 Oregon Convention Center, 777 NE Martin Luther King Jr Blvd, Room B113-114
📢 Learn more: ms.spr.ly/6016qSSUy
Join 👉 @KirollosPharmD @VictoriaNachar @jayinabox
#HOPA2025
Victoria Nachar retweeted
Myeloma Paper of the Day, March 5th, suggested by Robert Orlowski (@Myeloma_Doc)
@VictoriaNachar @kczmj
oncodaily.com/science/myelom…
#MyelomaPaperoftheDay #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews
Victoria Nachar retweeted
🌶️Hot off the press! 🌶️ Dexamethasone for CRS with teclistamab. You don't need toci for grade 1 CRS! great team work - @VictoriaNachar @CWagnerPharmD @kczmj @KLratermann @MikhailaPharmD @KG_PharmD @khouri_jack nature.com/articles/s41408-0…
Victoria Nachar retweeted
HOPA's OCC, with the participation of @ASCO Quality Training Programs, has developed practice-based tools to aid in developing and improving initiatives and the care of patients receiving oral anticancer agents (OAAs). Read the full article @JCO_ASCO: bit.ly/40YzPiV
Victoria Nachar retweeted
How do you treat low grade CRS due to myeloma bispecifics? We investigated differences of using dexamethasone and toci in CRS with teclistamab in six US centers and found as few as one 10mg dex dose is enough to alleviate low grade CRS. #ASH24 @VictoriaNachar @kczmj @j_snyder0132
Victoria Nachar retweeted
Time for a MANTLE CELL MASTERCLASS with @LymphClinician @ajperissinotti and @Berninini !
Should TRIANGLE change the SOC? Where do bispecifics and CAR-T fit into the treatment paradigm? Listen and find out! #lymsm #twitterx podcasters.spotify.com/pod/s…
Victoria Nachar retweeted
Bispecific antibodies are changing treatment in Hem/Onc.. but adoption has been mixed due to logistics! Out now in @JADPRO, we aim to tackle some FAQ!
🙏🏻 to @amirsali101 @thisisJamesD @SandahlTyler @VictoriaNachar @KPsiBCOP! #oncopharm #TwitterRx
jadpro.com/online-first/2024…
Victoria Nachar retweeted
Check out our latest episode "Myeloma Madness with the Myeloma Man", where @ajperissinotti and @Berninini discuss the recent FDA approval updates on CAR-T in myeloma with our good friend and myeloma expert @ManniMD1 podcasters.spotify.com/pod/s…
Victoria Nachar retweeted
Great Peer Exchange with an amazing group on myelofibrosis with @thisisJamesD @kczmj @VictoriaNachar and Shawn Griffin
pharmacytimes.com/view/myelo…
Dual target dilemma lead by the incredible @thisisJamesD
#epcoritamab vs #glofitamab battle of the bispecifics. hopefully the first of many collabs with @VictoriaNachar 👏🤓😎 #lymsm #oncopharm tandfonline.com/doi/full/10.…
The Taylor swift references - incredible. Literally 10/10. Chefs kiss. 🤌@ajperissinotti @Berninini @maddyochs @JustinArnall1
Newest episode is out! Join #teambadblood🩸as we go our own Eras Tour of Hemophilia treatment! @JustinArnall1 @maddyochs @Berninini @ajperissinotti #classicalhematology #itsnotbenign podcasters.spotify.com/pod/s…